Search Results

The president of Terre Haute Economic Development Corp. wants to look deeper into Pfizer Inc.’s troubles with its new inhaled insulin before Vigo County officials complete their offer of $4.5 million in tax-increment finance incentives for the plant that makes the product. Steve Witt told the County Council it would be “good business” to learn […]

Shrinking advertising revenue has persuaded the owners of Indy Men’s Magazine to stop publishing the free, glossy monthly after five years. Publisher Todd Tobias said the final, May issue will be distributed in late April: “As a monthly print publication, we’re done,” he said. Magazine parent Table Moose Media LLC is owned by Tobias, his […]

Eli Lilly and Co. is among 11 companies singled out by the mammoth California Public Employee Retirement System for “dismal stock performance” and poor corporate governance, according to Bloomberg. Lilly landed on Calpers’ annual “Focus List” for not allowing shareholders to amend company bylaws and by having tiers of board members that prevent the board […]

Safety jitters will cause sales of Eli Lilly and Co.’s Zyprexa schizophrenia drug to stop growing this year and stabilize at 2006 levels, CEO Sidney Taurel told reporters yesterday following a meeting at the Chief Executive’s Club at Boston College. The blockbuster drug has been blamed for weight gain and triggering diabetes in some patients. […]

The state of Montana has sued Eli Lilly and Co. for marketing its Zyprexa antipsychotic drug for off-label uses—the seventh state to make such claims. The lawsuit alleges the Indianapolis drugmaker owes the state for drug costs and harming patients after promoting the drug to sedate nursing home patients and giving kickbacks to doctors, according […]

Eli Lilly and Co. has agreed to buy Hypnion Inc., a Lexington, Mass., neuroscience drug research firm focused on sleep disorder. Financial terms were not disclosed. The acquisition is expected to close by the end of the month.

Eli Lilly and Co.’s antidepressant drug Cymbalta has been approved by the Food and Drug Administration to treat generalized anxiety disorder. About 6.5 million Americans suffer for the disorder. The drug is currently marketed to treat depression and to manage diabetes-related pain. In 2006, Cymbalta sales were $1.3 billion, up from $679 million the year […]

Eli Lilly and Co. today launched its first insulin injector pen with a digital memory in the hope of regaining market share lost in recent years to generic and inhalable insulin. HumaPen Memoir resembles a writing pen and is designed for patients who take several daily shots of insulin at mealtimes. The Indianapolis drugmaker said […]

Eli Lilly and Co. and other companies that make drugs for attention deficit hyperactivity disorder have been ordered by the U.S. Food and Drug Administration to develop handouts to give to patients warning of side affects. Some patients with heart problems have died suddenly or sustained strokes and heart attacks after taking the drugs, the […]

Eli Lilly and Co. has contracted with four companies to distribute its new line of drugs for dogs and cats. The companies include Butler Animal Health Supply of Dublin, Ohio; MWI Veterinary Supply of Nampa, Idaho; Professional Veterinary Products Ltd., of Omaha, Neb.; and Webster Veterinary Supply Inc., of Sterling, Mass. Indianapolis-based Lilly also said […]